Thymus- and activation-regulated chemokine (TARC) in serum/plasma associates with the disease activity of atopic dermatitis (AD), and is a promising tool for assessing the response to the treatment of the disease. TARC also exists within platelets, with elevated levels detectable in AD patients. We examined the effects of pre-analytical factors on the quantitation of TARC in human EDTA plasma. TARC levels in platelet-free plasma were significantly lower than those in platelet-containing plasma. After freeze-thaw, TARC levels increased in platelet-containing plasma, but remained unchanged in platelet-free plasma, suggesting TARC was released from the platelets during the freeze-thaw process. In contrast, TARC levels were stable in serum independent of freeze-thaw. These findings underscore the importance of pre-analytical factors to TARC quantitation. Plasma TARC levels should be measured in platelet-free plasma for accurate quantitation. Pre-analytical factors influence the quantitation, interpretation, and implementation of circulating TARC as a biomarker for the development of AD therapeutics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572979 | PMC |
| http://dx.doi.org/10.5772/61749 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes.
Diabet Med
December 2024
Institute of Metabolic Science - Medical Research Laboratories, University of Cambridge, Cambridge, UK.
Objectives: Gestational diabetes is diagnosed using an oral glucose tolerance test (OGTT), which has limited accuracy, reproducibility and practicality. We assessed the effect of enhanced pre-analytical glucose processing upon glucose concentrations, gestational diabetes diagnosis, health equity and pregnancy outcomes, and if HbA1c was a suitable alternative.
Methods: We recruited pregnant women with ≥1 risk factor to a prospective observational cohort study of pregnancy hyperglycaemia, endocrine causes, lipids, insulin and autoimmunity (OPHELIA), from nine UK centres.
Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets.
J Vis Exp
November 2024
Centro Cardiologico Monzino IRCCS; Department of Pharmaceutical Sciences, Università degli Studi di Milano;
A subset of circulating human platelets stores Tissue Factor (TF) intracellularly, the key activator of the blood coagulation cascade and thrombus formation. Upon platelet activation, TF is exposed on the cell membrane, where it binds to FVII, ultimately leading to thrombin generation. Considering that (1) levels of TF-positive platelets increase in various clinical settings, contributing to the patient's prothrombotic phenotype, and (2) different drugs can modulate platelet-associated TF expression, a standardized method for assessing TF-positive platelets is valuable, as its evaluation has been controversial in the past.
View Article and Find Full Text PDFImpact of Warm Ischemia Time on HER2 Expression in Breast Cancer Surgical Specimens.
Anticancer Res
December 2024
Department of Surgery, Yokohama City University, Yokohama, Japan.
Article Synopsis
- * A study involving 277 breast cancer patients examined the effects of WIT, CIT, and FT on the expression of estrogen receptors (ER), progesterone receptors (PgR), and HER2 in surgical specimens compared to preoperative biopsies.
- * Findings showed that while ER and PgR expressions tended to decrease with longer CIT and FT, only HER2 expression was significantly affected by WIT exceeding 30 minutes, indicating the importance of
ADNI Biomarker Core: A review of progress since 2004 and future challenges.
Alzheimers Dement
November 2024
Neurology Department, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Background: We describe the Alzheimer's Disease Neuroimaging Initiative (ADNI) Biomarker Core major activities from October 2004 to March 2024, including biobanking ADNI cerebrospinal fluid (CSF), plasma, and serum biofluid samples, biofluid analyses for Alzheimer's disease (AD) biomarkers in the Biomarker Core and various non-ADNI laboratories, and continuous assessments of pre-analytics.
Results: Validated immunoassay and mass spectrometry-based assays were performed in CSF with a shift to plasma, a more accessible biofluid, as qualified assays became available. Performance comparisons across different CSF and plasma AD biomarker measurement platforms have enriched substantially the ADNI participant database enabling method performance determinations for AD pathology detection and longitudinal assessments of disease progression.
Quality Control Circle Practices to Reduce Specimen Rejection Rates.
J Multidiscip Healthc
October 2024
Department of Nursing, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, People's Republic of China.
Background: Quality assurance in laboratory testing significantly impacts patient care. The pre-analytical phase is particularly error-prone, contributing to around 70% of laboratory errors. High specimen rejection rates can delay diagnosis and treatment, cause patient discomfort, and increase healthcare costs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!